참고문헌
- Lee TG CK, Chung KC, Choi JW. Prevalence of migraine in Korean adults: a nationwide survey. Korean J Headache 2000;1:57-66.
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1-211.
- Lee HJ, Kim YG, Kim ST. Diagnosis of headaches in dental clinic. J Dent Rehabil Appl Sci 2016;32:102-8. https://doi.org/10.14368/jdras.2016.32.2.102
- Kim BK, Cho SJ, Kim BS, Sohn JH, Kim SK, Cha MJ, Song TJ, Kim JM, Park JW, Chu MK, Park KY, Moon HS. Comprehensive Application of the International Classification of Headache Disorders Third Edition, Beta Version. J Korean Med Sci 2016;31:106-13. https://doi.org/10.3346/jkms.2016.31.1.106
- Brennum J, Brinck T, Schriver L, Wanscher B, Sorensen PS, Tfelt-Hansen P, Olesen J. Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache. Eur J Neurol 1996;3:23-8. https://doi.org/10.1111/j.1468-1331.1996.tb00184.x
- Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidencebased review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-62. https://doi.org/10.1212/WNL.55.6.754
- Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache 2015;55:3-20. https://doi.org/10.1111/head.12499
- Laurell K, Artto V, Bendtsen L, Hagen K, Haggstrom J, Linde M, Soderstrom L, Tronvik E, Wessman M, Zwart JA, Kallela M. Premonitory symptoms in migraine: A cross-sectional study in 2714 persons. Cephalalgia 2016;36:951-9. https://doi.org/10.1177/0333102415620251
- Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9. https://doi.org/10.1212/01.wnl.0000252808.97649.21
- Ashkenazi A, Blumenfeld A. OnabotulinumtoxinA for the treatment of headache. Headache 2013;53 Suppl 2:54-61. https://doi.org/10.1111/head.12185
- Steiner TJ, Gobel H, Jensen R, Lampl C, Paemeleire K, Linde M, Braschinsky M, Mitsikostas D, Gil-Gouveia R, Katsarava Z; European Headache Federation and Lifting The Burden: the Global Campaign against Headache. Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence. J Headache Pain 2019;20:24. https://doi.org/10.1186/s10194-019-0970-7
- Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001;56:S20-8. https://doi.org/10.1212/WNL.56.suppl_1.S20
- Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidencebased guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78:1337-45. https://doi.org/10.1212/WNL.0b013e3182535d20
-
$BOTOX^{(R)}$ Chronic Migraine Reconstitution and Injection Workshop Guide. In: Allergan I, editor; 2010. - Cefaly. Available from: https://www.cefaly.us/en/migraine-treatment-cefaly (Updated 2019 Sep 4).